Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Jasper Therapeutics Inc., 3 years.
Jasper Therapeutics Inc.
Director
Oruka Therapeutics Inc.
Director · Chief Executive Officer
Jade Biosciences Inc.
Director
Chief executive roles
Oruka Therapeutics Inc.
· President and CEO
Since August 2024
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Oruka Therapeutics Inc. June 2, 202699.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Oruka Therapeutics Inc. | Open-market sale | −2,452 | $95.71 | $234,681 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Option exercise | +75,000 | $7.80 | $585,000 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −6,604 | $90.79 | $599,556 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −63,596 | $91.90 | $5,844,237 |
| Sep 1, 2026 | Oruka Therapeutics Inc. | Open-market sale | −4,800 | $92.44 | $443,691 |
| Jun 15, 2026 | Oruka Therapeutics Inc. | Open-market sale | −1,729 | $69.69 | $120,494 |
| Mar 16, 2026 | Oruka Therapeutics Inc. | Open-market sale | −1,729 | $41.30 | $71,408 |
| Jan 23, 2026 | Oruka Therapeutics Inc. | Grant or award | +76,700 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.